Hotchkis & Wiley Capital Management
ORGO icon

Hotchkis & Wiley Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-873,090
Closed -$2.9M – 515
2023
Q2 		$2.9M Buy
873,090
+31,890
+4% +$94.2K 0.01% 418
2023
Q1 		$1.79M Buy
841,200
+484,970
+136% +$1.2M 0.01% 469
2022
Q4 		$958K Buy
+356,230
New +$1.04M ﹤0.01% 482

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Hotchkis & Wiley Capital Management's ORGO Position: Q3 2023 in Review

Hotchkis & Wiley Capital Management sold out of Organogenesis Holdings (ORGO) in Q3 2023, closing a stake of 873,090 shares — an estimated $2.9M sold.

Hotchkis & Wiley Capital Management first reported a position in ORGO in Q4 2022 and held it in 3 quarters. The position peaked at $2.9M in Q2 2023. 104 funds tracked by Wall St. Rank hold ORGO as of Q3 2023.

  • Hotchkis & Wiley Capital Management reported no remaining Organogenesis Holdings position as of Q3 2023 after selling out during the quarter.
  • Hotchkis & Wiley Capital Management sold 873,090 Organogenesis Holdings shares in Q3 2023, an estimated $2.9M.
  • Hotchkis & Wiley Capital Management first reported a position in Organogenesis Holdings in Q4 2022 and held it in 3 quarters.
  • Hotchkis & Wiley Capital Management's Organogenesis Holdings position peaked at $2.9M in Q2 2023.
  • 104 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2023.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.